A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Non-Elderly Adults and Elderly Subjects
Clinical trial NCT01759654 · COMPLETED
Trial details
- NCT number
- NCT01759654
- Sponsor
- Adimmune Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-24
- Primary completion
- 2012-12-25
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.